*	OR T1 T2
R1	Has_value Arg1:T4 Arg2:T5	
R2	Has_value Arg1:T6 Arg2:T5	
*	OR T4 T6
R3	Has_index Arg1:T7 Arg2:T8	
R4	Has_temporal Arg1:T5 Arg2:T7	
R5	AND Arg1:T9 Arg2:T13	
R6	Has_temporal Arg1:T9 Arg2:T14	
R7	AND Arg1:T9 Arg2:T15	
R8	AND Arg1:T9 Arg2:T16	
R9	AND Arg1:T9 Arg2:T17	
R10	Has_value Arg1:T21 Arg2:T20	
R11	Has_value Arg1:T28 Arg2:T29	
R12	Has_value Arg1:T26 Arg2:T27	
R13	Has_negation Arg1:T30 Arg2:T31	
*	OR T35 T36
R14	Has_temporal Arg1:T39 Arg2:T38	
R15	Has_value Arg1:T40 Arg2:T41	
R16	Subsumes Arg1:T43 Arg2:T44	
R17	Has_value Arg1:T42 Arg2:T43	
R18	Subsumes Arg1:T39 Arg2:T40	
R19	Subsumes Arg1:T37 Arg2:T39	
*	OR T32 T39
R20	Subsumes Arg1:T30 Arg2:T37	
R21	Has_value Arg1:T50 Arg2:T51	
R22	Has_value Arg1:T68 Arg2:T72	
R23	Has_value Arg1:T73 Arg2:T74	
R24	Has_value Arg1:T77 Arg2:T78	
*	OR T79 T80
R25	Has_temporal Arg1:T83 Arg2:T84	
R26	Subsumes Arg1:T82 Arg2:T77	
R27	Has_value Arg1:T82 Arg2:T78	
R28	Has_qualifier Arg1:T82 Arg2:T79	
R29	Has_qualifier Arg1:T77 Arg2:T79	
R30	AND Arg1:T82 Arg2:T83	
R31	AND Arg1:T77 Arg2:T83	
R32	Subsumes Arg1:T39 Arg2:T42	
*	OR T33 T39
*	OR T35 T39
R35	Has_value Arg1:T69 Arg2:T72	
R36	Has_value Arg1:T70 Arg2:T72	
T1	Person 0 4	Male
T2	Person 9 16	females
T3	Grammar_Error 5 8	and
T4	Person 17 21	aged
T5	Value 22 45	between 18 and 65 years
T6	Person 49 52	age
T7	Temporal 64 107	at the time of signing the informed consent
T8	Reference_point 79 107	signing the informed consent
T9	Condition 110 117	Healthy
T10	Qualifier 118 174	as determined by a responsible and experienced physician
T11	Subjective_judgement 118 174	as determined by a responsible and experienced physician
T12	Undefined_semantics 118 174	as determined by a responsible and experienced physician
T13	Procedure 187 205	medical evaluation
T14	Temporal 216 231	medical history
T15	Procedure 233 253	physical examination
T16	Procedure 255 271	laboratory tests
T17	Procedure 276 294	cardiac monitoring
T18	Condition 313 333	clinical abnormality
T19	Context_Error 370 436	are not specifically listed in the inclusion or exclusion criteria
T20	Value 438 465	outside the reference range
T21	Measurement 337 357	laboratory parameter
T22	Undefined_semantics 337 357	laboratory parameter
T23	Context_Error 499 514	may be included
T24	Non-query-able 296 731	A subject with a clinical abnormality or laboratory parameter(s) which is/are not specifically listed in the inclusion or exclusion criteria, outside the reference range for the population being studied may be included only if the Investigator in consultation with the GSK Medical Monitor if required agree and document that the finding is unlikely to introduce additional risk factors and will not interfere with the study procedures.
T25	Post-eligibility 296 728	A subject with a clinical abnormality or laboratory parameter(s) which is/are not specifically listed in the inclusion or exclusion criteria, outside the reference range for the population being studied may be included only if the Investigator in consultation with the GSK Medical Monitor if required agree and document that the finding is unlikely to introduce additional risk factors and will not interfere with the study procedur
T26	Measurement 733 744	Body weight
T27	Value 745 764	>= 50 kilogram (kg)
T28	Measurement 769 784	body mass index
T29	Value 785 818	within the range 19 - 24.9 kg/m^2
T30	Condition 895 917	childbearing potential
T31	Negation 891 894	Non
T32	Condition 929 943	pre-menopausal
T33	Person 944 951	females
T34	Person 835 841	female
T35	Procedure 970 984	tubal ligation
T36	Procedure 988 1000	hysterectomy
T37	Condition 1247 1261	postmenopausal
T38	Temporal 1273 1282	12 months
T39	Condition 1286 1308	spontaneous amenorrhea
T40	Measurement 1365 1399	follicle stimulating hormone (FSH)
T41	Value 1400 1454	> 40 milli-international units per milliliter (MlU/mL)
T42	Measurement 1459 1468	estradiol
T43	Value 1469 1505	< 40 picograms per mililiter (pg/mL)
T44	Value 1507 1530	<147 picomole per liter
T48	Procedure 1561 1594	hormone replacement therapy (HRT)
T49	Person 1550 1557	Females
T50	Measurement 1605 1622	menopausal status
T51	Value 1626 1634	in doubt
T52	Not_a_criteria 1550 1744	Females on hormone replacement therapy (HRT) and whose menopausal status is in doubt will be required to use one of the contraception methods if they wish to continue their HRT during the study.
T53	Parsing_Error 1745 1856	Otherwise, they must discontinue HRT to allow confirmation of post-menopausal status prior to study enrollment.
T54	Not_a_criteria 1745 1856	Otherwise, they must discontinue HRT to allow confirmation of post-menopausal status prior to study enrollment.
T55	Parsing_Error 1550 1744	Females on hormone replacement therapy (HRT) and whose menopausal status is in doubt will be required to use one of the contraception methods if they wish to continue their HRT during the study.
T56	Parsing_Error 1857 2016	For most forms of HRT, at least 2-4 weeks will elapse between the cessation of therapy and the blood draw; this interval depends on the type and dosage of HRT.
T57	Not_a_criteria 1857 2016	For most forms of HRT, at least 2-4 weeks will elapse between the cessation of therapy and the blood draw; this interval depends on the type and dosage of HRT.
T58	Parsing_Error 2017 2553	Following confirmation of their post-menopausal status, they can resume use of HRT during the study without use of a contraceptive method; Child-bearing potential with negative pregnancy test as determined by serum human chorionic gonadotrophin (hCG) test at screening or prior to dosing AND; Agrees to use one of the contraception methods listed in protocol for an appropriate period of time (as determined by the product label or investigator) prior to the start of dosing to sufficiently minimize the risk of pregnancy at that point.
T59	Post-eligibility 2017 2553	Following confirmation of their post-menopausal status, they can resume use of HRT during the study without use of a contraceptive method; Child-bearing potential with negative pregnancy test as determined by serum human chorionic gonadotrophin (hCG) test at screening or prior to dosing AND; Agrees to use one of the contraception methods listed in protocol for an appropriate period of time (as determined by the product label or investigator) prior to the start of dosing to sufficiently minimize the risk of pregnancy at that point.
T60	Not_a_criteria 2554 2715	Female subjects must agree to use contraception until the follow-up contact visit; OR has only same-sex partners, when this is her preferred and usual lifestyle.
T61	Non-query-able 2554 2715	Female subjects must agree to use contraception until the follow-up contact visit; OR has only same-sex partners, when this is her preferred and usual lifestyle.
T62	Post-eligibility 2554 2715	Female subjects must agree to use contraception until the follow-up contact visit; OR has only same-sex partners, when this is her preferred and usual lifestyle.
T63	Context_Error 2717 2849	Male subjects with female partners of child-bearing potential must agree to use one of the contraception methods listed in Protocol.
T64	Post-eligibility 2717 2849	Male subjects with female partners of child-bearing potential must agree to use one of the contraception methods listed in Protocol.
T65	Parsing_Error 2850 2968	This criterion must be followed from the time of the first dose of study medication until the follow-up contact visit.
T66	Post-eligibility 2850 2968	This criterion must be followed from the time of the first dose of study medication until the follow-up contact visit.
T67	Non-query-able 2970 3105	Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form
T68	Measurement 3107 3131	Alanine aminotransferase
T69	Measurement 3133 3153	alkaline phosphatase
T70	Measurement 3158 3167	bilirubin
T72	Value 3168 3202	<=1.5x upper limit of normal (ULN)
T73	Measurement 3213 3222	bilirubin
T74	Value 3223 3231	>1.5xULN
T75	Measurement 3279 3295	direct bilirubin
T76	Grammar_Error 3203 3301	(isolated bilirubin >1.5xULN is acceptable if bilirubin is fractionated and direct bilirubin <35%)
T77	Measurement 3440 3444	QTcF
T78	Value 3445 3455	< 450 msec
T79	Qualifier 3313 3319	single
T80	Qualifier 3323 3331	averaged
T82	Measurement 3332 3359	corrected QT interval (QTc)
T83	Procedure 3381 3399	electrocardiograms
T84	Temporal 3409 3438	over a brief recording period
